US Government Announces Plans for Domestic Monkeypox Vaccine Production

August 22, 2022

In an announcement last week, the US Department of Health and Human Services (DHS) revealed a new deal between Bavarian Nordic and Grand River Aseptic Manufacturing (GRAM). The agreement will allow GRAM to manufacture Bavarian Nordic’s Jynneos monkeypox vaccine stateside. GRAM will produce 2.5 million vials from a store of bulk vaccines, hopefully ramping up access for at-risk populations.

According to Bob Fenton, Coordinator of the White House National Monkeypox Response, “Rapidly increasing the supply and safe delivery of monkeypox vaccine to those at the highest risk of contracting the virus is a top priority for President Biden. This partnership between Bavarian Nordic and GRAM will significantly increase the capacity to fill and finish government-owned doses – for the first time in the U.S. – and allow us to deliver our current and future supply more quickly to locations nationwide”

To read more, click here.

(Source: Medical Economics, August 19th, 2022)

Share This Story!